Literature DB >> 11127161

Bupropion to aid smoking cessation.

.   

Abstract

Around 1 in 4 adults in the UK smoke cigarettes and about two-thirds say they would like to give them up. However, giving up permanently is difficult, and each year, only about 2% of all smokers manage to do so. [symbol: see text]Bupropion (Zyban-GlaxoWellcome) has recently been licensed "as an aid to smoking cessation in combination with motivational support". The manufacturer claims that there is evidence that the drug is "almost twice as effective as a nicotine patch in achieving smoking abstinence at one year". Here, we assess the efficacy and safety of bupropion in helping people stop smoking.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127161     DOI: 10.1136/dtb.2000.381073

Source DB:  PubMed          Journal:  Drug Ther Bull        ISSN: 0012-6543


  3 in total

Review 1.  Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation.

Authors:  Andrew J Johnston; John Ascher; Robert Leadbetter; Virginia D Schmith; Dipak K Patel; Michael Durcan; Beth Bentley
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort.

Authors:  Teresa R Franklin; Ze Wang; Yin Li; Jesse J Suh; Marina Goldman; Falk W Lohoff; Jeffrey Cruz; Rebecca Hazan; Will Jens; John A Detre; Wade Berrettini; Charles P O'Brien; Anna Rose Childress
Journal:  Addict Biol       Date:  2011-02-08       Impact factor: 4.280

Review 3.  The use of bupropion SR in cigarette smoking cessation.

Authors:  Scott Wilkes
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.